Stay updated on MAPP2 MDMA Therapy Clinical Trial

Sign up to get notified when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPP2 MDMA Therapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The sponsor line now shows Resilient Pharmaceuticals as sponsor and responsible party, replacing Lykos Therapeutics. This change reflects a shift in the organization overseeing the study.
    Difference
    0.2%
    Check dated 2026-05-01T09:22:58.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s footer revision marker was updated from v3.5.2 to v3.5.3, indicating a general platform/version change without affecting the listed clinical trial study information.
    Difference
    0.0%
    Check dated 2026-04-24T06:27:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:49:07.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Template revision updated to v3.5.0, replacing v3.4.3. No user-facing content or study data are affected.
    Difference
    0.0%
    Check dated 2026-03-19T06:24:17.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:35:38.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.2 appears on the page, and previous revision notices (v3.4.1) and related funding notices have been updated or removed. These are administrative site updates and do not modify the study content or how users interact with the page.
    Difference
    0.4%
    Check dated 2026-02-11T12:33:26.000Z thumbnail image

Stay in the know with updates to MAPP2 MDMA Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.